Global Blood Transfusion Sales Market Size By Type (Y-type, Straiht), By Application (Child, Adult), By Region, And Segment Forecasts, 2023 to 2032

lobal Blood Transfusion Sales Market Report Description

The Global Blood Transfusion Sales Market was valued at USD 7.2 billion in 2023 and is projected to surpass USD 12.6 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2023–2031).

The market growth is driven by the rising prevalence of chronic diseases, increasing surgical procedures, trauma cases, and the growing demand for advanced transfusion technologies. The aging global population and improved healthcare infrastructure in emerging economies are also boosting the need for safe and efficient blood transfusion products and services. Furthermore, advancements in blood screening, storage, and transportation technologies have significantly enhanced the safety and availability of transfusion products, thereby fueling market expansion.

Drivers

Rising Prevalence of Chronic and Hematological Disorders

Chronic conditions like cancer, anemia, hemophilia, and kidney diseases have increased the demand for blood and plasma transfusions globally. Regular transfusions are essential for managing these diseases, driving market growth.

Increasing Number of Surgeries and Trauma Cases

The growing rate of complex surgical procedures, organ transplants, and road accidents has amplified the need for reliable blood transfusion services. Hospitals and trauma centers require a steady blood supply to manage critical cases effectively.

Technological Advancements in Blood Transfusion Products

Innovations such as pathogen reduction technologies, advanced blood storage systems, and automated transfusion devices are improving efficiency and safety, boosting adoption rates worldwide.

Restraints

Risk of Transfusion-Transmitted Infections (TTIs)

Despite advancements in screening technologies, the risk of TTIs and allergic reactions remains a significant challenge, affecting patient trust and adoption in certain regions.

High Cost of Advanced Transfusion Technologies

The high initial investment required for advanced screening systems, pathogen reduction devices, and automated transfusion equipment can limit market penetration, especially in low-income countries.

Opportunities

Expansion in Emerging Markets

Developing countries in Asia-Pacific, Latin America, and Africa are increasingly investing in healthcare infrastructure, creating vast opportunities for blood transfusion equipment manufacturers and service providers.

Growth of Blood Banks and Donation Campaigns

Public awareness campaigns and government initiatives to promote voluntary blood donations are improving the availability of blood products, thus fueling market growth.

Adoption of AI and Digital Solutions

Integrating artificial intelligence and digital health platforms into transfusion services can improve blood inventory management, patient matching, and safety protocols, creating new growth avenues.

Market by System Type Insights

Based on system type, the Whole Blood Collection and Processing Equipment segment accounted for the largest market share in 2023. The demand for reliable collection and safe processing systems remains high due to their extensive use in hospitals and blood banks. However, the Pathogen Reduction and Safety Technologies segment is projected to grow at the highest CAGR, driven by rising concerns over infection control and the adoption of cutting-edge transfusion safety solutions.

Market by End-Use Insights

In terms of end-use, the Hospitals & Clinics segment dominated the market in 2023, contributing over 45% of the total revenue. The increasing volume of surgeries, trauma care, and disease management procedures in hospitals ensures consistent demand for transfusion services. Meanwhile, Standalone Blood Banks are expected to see rapid growth, supported by increased government funding and partnerships with non-profit organizations for blood collection and supply.

Market by Regional Insights

North America led the global blood transfusion sales market in 2023, owing to advanced healthcare infrastructure, strong government support, and a high prevalence of chronic diseases.

Europe follows closely due to its robust blood donation systems and the widespread adoption of transfusion safety technologies.

Asia-Pacific is expected to witness the fastest growth during the forecast period, fueled by improving healthcare facilities, rising awareness of blood donation, and the high incidence of road accidents and trauma cases in countries like India and China.

Latin America and the Middle East & Africa are also emerging markets with growing demand for blood transfusion services due to improving medical infrastructure and increasing healthcare investments.

Competitive Scenario

Key players in the Global Blood Transfusion Sales Market include Grifols S.A., Terumo BCT, Fresenius Kabi AG, Haemonetics Corporation, Macopharma, Immucor, Becton Dickinson (BD), and Kawasumi Laboratories.

These companies focus on strategic collaborations, product innovation, and geographic expansion to strengthen their market presence.

In 2023, Terumo BCT launched an advanced pathogen reduction system to enhance transfusion safety.

Grifols partnered with major blood banks in Europe in 2024 to expand its plasma collection network.

Fresenius Kabi introduced a new line of portable transfusion devices in 2025 for emergency and field use.

Scope of Work – Global Blood Transfusion Sales Market

Key Market Developments

2023: Terumo BCT launched a next-generation automated blood processing system, improving efficiency in blood banks.

2024: Grifols expanded its plasma collection network across Europe with strategic partnerships.

2025: Fresenius Kabi introduced portable transfusion devices for emergency care and disaster relief.

FAQs

What is the current market size of the Global Blood Transfusion Sales Market?

The market size was USD 7.2 billion in 2023.

What is the major growth driver of the Global Blood Transfusion Sales Market?

The major growth drivers include the rising prevalence of chronic diseases, increasing surgical procedures, and advancements in transfusion safety technologies.

Which is the largest region during the forecast period in the Global Blood Transfusion Sales Market?

North America is expected to remain the largest region due to its advanced healthcare infrastructure and high adoption of innovative transfusion technologies.

Which segment accounted for the largest market share in the Global Blood Transfusion Sales Market?

The Hospitals & Clinics segment accounted for the largest share in 2023.

Who are the key market players in the Global Blood Transfusion Sales Market?

Major players include Grifols S.A., Terumo BCT, Fresenius Kabi AG, Haemonetics Corporation, and Macopharma.

Would you like me to also create a graphical chart (e.g., CAGR projection or regional share) and a brief SEO-optimized meta description for this market?